Search - tctmd.com

Displaying 161 - 180 of 191

Sort: Relevancy | Date

Presentation VEINS 2013

Difficult Anticoagulation Decisions: Case 1

Presenter: Teresa L. Carman

September 22, 2013

Presentation VEINS 2013

Proper Duration of Anticoagulation: Can This Be Patient Specific?

Presenter: Michael R. Jaff

September 21, 2013

Presentation VEINS 2013

Difficult Anticoagulation Decisions

Presenter: John R. Bartholomew

September 21, 2013

Presentation VEINS 2013

Antiplatelets, Anticoagulation Post Intervention and Surveillance

Presenter: John R. Bartholomew

September 20, 2013

Presentation

Use and Associated Risks of Concomitant Aspirin with Oral Anticoagulation in A-fib Patients

Presenter: B. A. Steinberg

July 24, 2013

Presentation

Risks and Benefits of Anticoagulation in Atrial Fibrillation

Presenter: MW Cullen

June 20, 2013

Presentation TVT 2013

Who Is Really Contraindicated for Oral Anticoagulation Therapy? Are There Absolute Guidelines?

Presenter: Steven Goldberg

June 15, 2013

Presentation TVT 2013

LAA Closure for the Anticoagulation Intolerant Patient: Data and Common Sense

Presenter: Matthew Price

June 15, 2013

Presentation TVT 2013

Is Triple Therapy a Triple Threat for Patients? DAPT and Chronic Anticoagulation

Presenter: Ted Feldman

June 15, 2013

Presentation TVT 2013

"New" Anticoagulation Options for A-fib: Beyond Warfarin

Presenter: Michael Ezekowitz

June 15, 2013

Presentation

Oral Anticoagulation (OAC) and Antiplatelets inA-fib Patients After MI and PCI

Presenter: M. Lamberts

June 12, 2013

Presentation TCT Russia 2013

Emerging Anticoagulation Strategies for Elective PCI

Presenter: Roxana Mehran

June 09, 2013

Presentation

Percutaneous LAA Closure with the Amplatzer Cardiac Plug in Patients with Nonvalvular A-fib and Contraindications for Anticoagulation Therapy

Presenter: M. Urena

May 28, 2013

Presentation

LAA Closure with the Watchman Device in Patients with a Contraindication for Oral Anticoagulation

Presenter: Vivek Y. Reddy

April 09, 2013

Presentation PCI Outcomes 2013

DAPT + Oral Anticoagulation: Indications and Risk Amelioration

Presenter: C. Michael Gibson

March 07, 2013

Presentation TCT 2013

The Impact Of Upstream Anticoagulation On In-Hospital Bleeding In Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2013

Cost-effectiveness Of Transcatheter Left Atrial Appendage Occlusion Compared With 5 Alternative Anticoagulation Strategies For Stroke Prevention In Atrial Fibrillation: A Markov...

Presenter: Bryan Yan, Chow Innes, Yat Yin Lam, Vivian Lee, Cheuk Man Yu

January 31, 2013

Presentation TCT 2013

Can the Rate of Acute Stent Thrombosis with Bivalirudin Anticoagulation During Primary PCI in STEMI be Reduced with Modified Pharmacologic Regimens?

Presenter: Andreas Baumbach, Harold Dauerman, Bernardo Cortese, Martial Hamon, Jayne Prats, Efthymios Deliargyris, Roxana Mehran, Gregg Stone

January 31, 2013

Presentation

Initial Experience with a Novel Percutaneous LAA Exclusion Device in Pts with A-fib, Increased Stroke Risk, and Contraindications to Anticoagulation

Presenter: A. Massumi

January 14, 2013

Presentation TCT 2012

Anticoagulation Choices for Atrial Fibrillation: Which Drug for Which Patient?

Presenter: Michael Ezekowitz

October 24, 2012

Advertisement

Difficult Anticoagulation Decisions: Case 1

Proper Duration of Anticoagulation: Can This Be Patient Specific?

Difficult Anticoagulation Decisions

Antiplatelets, Anticoagulation Post Intervention and Surveillance

Use and Associated Risks of Concomitant Aspirin with Oral Anticoagulation in A-fib Patients

Risks and Benefits of Anticoagulation in Atrial Fibrillation

Who Is Really Contraindicated for Oral Anticoagulation Therapy? Are There Absolute Guidelines?

LAA Closure for the Anticoagulation Intolerant Patient: Data and Common Sense

Is Triple Therapy a Triple Threat for Patients? DAPT and Chronic Anticoagulation

"New" Anticoagulation Options for A-fib: Beyond Warfarin

Oral Anticoagulation (OAC) and Antiplatelets inA-fib Patients After MI and PCI

Emerging Anticoagulation Strategies for Elective PCI

Percutaneous LAA Closure with the Amplatzer Cardiac Plug in Patients with Nonvalvular A-fib and Contraindications for Anticoagulation Therapy

LAA Closure with the Watchman Device in Patients with a Contraindication for Oral Anticoagulation

DAPT + Oral Anticoagulation: Indications and Risk Amelioration

The Impact Of Upstream Anticoagulation On In-Hospital Bleeding In Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Cost-effectiveness Of Transcatheter Left Atrial Appendage Occlusion Compared With 5 Alternative Anticoagulation Strategies For Stroke Prevention In Atrial Fibrillation: A Markov...

Can the Rate of Acute Stent Thrombosis with Bivalirudin Anticoagulation During Primary PCI in STEMI be Reduced with Modified Pharmacologic Regimens?

Initial Experience with a Novel Percutaneous LAA Exclusion Device in Pts with A-fib, Increased Stroke Risk, and Contraindications to Anticoagulation

Anticoagulation Choices for Atrial Fibrillation: Which Drug for Which Patient?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content